YC
Publicaties op Oncologisch.com
Sequentieel afatinib en osimertinib versus afatinib en chemotherapie bij EGFR-gemuteerd NSCLC: Taiwanese data
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non-Small Cell Lung Cancer...
Adjuvant atezolizumab na adjuvante chemotherapie bij gereseceerd NSCLC: IMpower010 fase III